Media Contact: Jeremy Lechan508-333-4852jlechan@tuftsmedicalcenter.org Internationally esteemed “think and do” tank moved to the new Center for Biomedical System Design within Tufts MC’s Institute for Clinical Research and Health Policy Studies … Read More
NEWDIGS welcomes Takeda Pharmaceuticals as a new collaborator in the LEAPS Project
Takeda Pharmaceutical, a global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide, has joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s New … Read More
FoCUS Monthly Recap: April 2022
RESEARCH BRIEF How can self-insured employers prepare for the portfolio impact of high-cost gene therapies coming to market? Self-insured employers currently rely on traditional stop-loss insurance to protect against unexpected … Read More
LEAPS Monthly Recap: April 2022
NEW MEMBER NEWDIGS welcomes Takeda Pharmaceuticals as a new collaborator in the LEAPS Project Takeda Pharmaceutical, a global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people … Read More
How can self-insured employers prepare for the portfolio impact of highcost gene therapies coming to market?
Self-insured employers (SIEs) currently rely on traditional stop-loss insurance to protect against unexpected high-cost claims, including those for cell and gene therapies. Given that current approvals are in rare diseases, … Read More
FoCUS Monthly Recap: February 2022
JUST RELEASED Paying for Cures Toolkit updated with new pipeline modeling and financing strategies FoCUS released an updated and expanded version of its Paying for Cures Toolkit, which is designed to … Read More
LEAPS Monthly Recap: February 2022
WE’RE GROWING NEWDIGS searching for new director, program manager We’re searching for Director and Program manager talent—join our interdisciplinary think-and-do tank designing solutions to make biopharma and healthcare systems more … Read More
LEAPS leadership news: Kay Larholt retires, Fotios Kokkotos joins
In February 2022, Kay Larholt retired from her role as Director of Research for NEWDIGS, to stay on as a Senior Advisor. Fotios Kokkotos joined as NEWDIGS’ Director of Data … Read More
Data for modelling US projections of product approvals, patients treated, and product revenues for durable cell and gene therapies
Data in Brief, 41, 107891.Young, C. M., Trusheim, M., & Quinn, C. (2022). The recent marketing approval of several durable gene and cell therapies (2017-2020), together with observations that 7,000 … Read More
FoCUS Monthly Recap: January 2022
JUST RELEASED Paying for Cures Toolkit updated with new pipeline modeling and financing strategies Today FoCUS released an updated and expanded version of its Paying for Cures Toolkit, which is designed … Read More